Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater China
- Written by ACN Newswire - Press Releases
Read more //?#
.
Tacking the skills shortage — why L&D is failing and what to do about it
The Australian economy is in a tough spot right now, and a huge part of the problem is a massive skills shortage. Late last year, businesses were st...
How reducing revenue leakage could help your business stay in the black in FY2026
It’s time to stop legacy revenue management platforms and processes draining your profitability. Is boosting the bottom line an overarching goal ...
Technical Debt Stifling Path to AI Adoption for Global Enterprises
Outdated legacy technologies costing organisations the ability to innovate, money, time and potentially, even customers Technical debt and an ov...
Attract. Impress. Keep. The new small business growth playbook
Running a small business is a marathon that often feels like a sprint. You are chasing leads, juggling admin, building a brand and trying to carve...
Amazon to expand data centre infrastructure in Australia and strengthen AI
Amazon has announced plans to invest a new total of AU$20 billion from 2025 to 2029 to expand, operate, and maintain its data centre infrastructur...
How AI is Reshaping Banking in Australia
AI in the Banking and Financial Services Industry From fraud detection and credit scoring to personalised financial advice, AI is transforming t...
